Publications by authors named "Charles Humfrey"

Claim this Profile
L
Letter to the Editors regarding "10% body weight (gain) change as criterion for the maximum tolerated dose: A critical analysis".
Josje H E Arts, Charles D Humfrey, Eddie D Sloter

Regul Toxicol Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of the GARD™skin applicability domain: Indirectly acting haptens, hydrophobic substances and UVCBs.
Andy Forreryd, Robin Gradin, Charles Humfrey, Len Sweet, Henrik Johansson

ALTEX· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The chemokine CXCR2 antagonist (AZD5069) preserves neutrophil-mediated host immunity in non-human primates.
Mohib Uddin, Catherine Betts, Ian Robinson, Anna Malmgren, Charles Humfrey

Haematologica· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions.
Stipo Jurcevic, Charles Humfrey, Mohib Uddin, Steve Warrington, Bengt Larsson

Br J Clin Pharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent developments in the risk assessment of potentially genotoxic impurities in pharmaceutical drug substances.
Charles D N Humfrey

Toxicol Sci· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity.
Lutz Müller, Robert J Mauthe, Christopher M Riley, Marta M Andino, David De Antonis, Charles D N Humfrey

Regul Toxicol Pharmacol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis